Genome Engineering for Humanity
PIPELINE
HM-101
Monoclonal antibody
HM-101
Autoimmune disease
- Inflammation & Immunology
- Discovery stage
- T-cell immune modulator
-
Indications
Autoimmune disease
-
Mechanism of Action
HM-101 is a fully human monoclonal antibody that targets pro-inflammatory cytokines, dampening the downstream signaling pathways that are aberrantly upregulated in various autoimmune conditions.
-
Development status
This early discovery asset is currently set for preclinical studies.